What is Nurix Therapeutics, Inc. Common stock's Market Cap?

Nurix Therapeutics, Inc. Common stock's Market Cap is $2.7B, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's Enterprise Value?

Nurix Therapeutics, Inc. Common stock's Enterprise Value is $2.7B, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's Price / Sales?

Nurix Therapeutics, Inc. Common stock's Price / Sales is 74.1×, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's EV / Revenue?

Nurix Therapeutics, Inc. Common stock's EV / Revenue is 72.3×, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's EV / EBITDA?

Nurix Therapeutics, Inc. Common stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's Revenue (TTM)?

Nurix Therapeutics, Inc. Common stock's Revenue (TTM) is $36.8M, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's Net Income (TTM)?

Nurix Therapeutics, Inc. Common stock's Net Income (TTM) is -$341.4M, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's EBITDA?

Nurix Therapeutics, Inc. Common stock's EBITDA is -$352.6M, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's Diluted EPS (TTM)?

Nurix Therapeutics, Inc. Common stock's Diluted EPS (TTM) is -3.29, based on as-reported figures from SEC (XBRL) filings.

What is Nurix Therapeutics, Inc. Common stock's EBITDA Margin?

Nurix Therapeutics, Inc. Common stock's EBITDA Margin is -959.0%, based on as-reported figures from SEC (XBRL) filings.

Nurix Therapeutics, Inc. Common stock (NRIX) Financial Statements

Nurix Therapeutics, Inc. Common stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00SDJ8M87

XNAS · usd

26.26▲ 0.13 (0.50%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close26.13

Day's Range25.91 – 26.70

52-Week Range8.20 – 28.23

Volume988.6K

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees357

ExchangeXNAS

Listed2020-07-24

Share count as of June 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Nurix Therapeutics, Inc. Common stock (NRIX)

What is Nurix Therapeutics, Inc. Common stock's Market Cap?: Nurix Therapeutics, Inc. Common stock's Market Cap is $2.7B, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's Enterprise Value?: Nurix Therapeutics, Inc. Common stock's Enterprise Value is $2.7B, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's Price / Sales?: Nurix Therapeutics, Inc. Common stock's Price / Sales is 74.1×, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's EV / Revenue?: Nurix Therapeutics, Inc. Common stock's EV / Revenue is 72.3×, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's EV / EBITDA?: Nurix Therapeutics, Inc. Common stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's Revenue (TTM)?: Nurix Therapeutics, Inc. Common stock's Revenue (TTM) is $36.8M, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's Net Income (TTM)?: Nurix Therapeutics, Inc. Common stock's Net Income (TTM) is -$341.4M, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's EBITDA?: Nurix Therapeutics, Inc. Common stock's EBITDA is -$352.6M, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's Diluted EPS (TTM)?: Nurix Therapeutics, Inc. Common stock's Diluted EPS (TTM) is -3.29, based on as-reported figures from SEC (XBRL) filings.
What is Nurix Therapeutics, Inc. Common stock's EBITDA Margin?: Nurix Therapeutics, Inc. Common stock's EBITDA Margin is -959.0%, based on as-reported figures from SEC (XBRL) filings.